Efficacy and safety testing: The clinical perspective

Current Problems in Dermatology

Volumn 34, Issue , 2007, Pages 33-46

  Fluhr, Joachim W ^a   Miteva, M ^a   Elsner, P ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; HUMAN; OCCUPATIONAL DISEASE; REPRODUCIBILITY; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; TOXICITY TESTING;

ADMINISTRATION, TOPICAL; DERMATOLOGIC AGENTS; HUMANS; OCCUPATIONAL DISEASES; REPRODUCIBILITY OF RESULTS; SKIN DISEASES; SKIN IRRITANCY TESTS;

EID: 33847341150     PISSN: 14215721     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000099602     Document Type: Article

References (39)

1. Harding C: The stratum corneum: structure and function in health and disease. Dermatol Ther 2004;17:6-15.
2. Forslind B: A domain mosaic model of the skin barrier. Acta Derm Venereol 1994;74:1-6.
3. Bornkessel A, Flach M, Arens-Corell M, Elsner P, Fluhr JW: Functional assessment of a washing emulsion for sensitive skin: mild impairment of stratum corneum hydration, pH, barrier function, lipid content, integrity and cohesion in a controlled washing test. Skin Res Technol 2005;11:53-60.
4. Fluhr JW, Ennen J: Standardized washing models: facts and requirements. Skin Res Technol 2004;10:141-143.
5. Kiesken J, Klotz A: Occupational skin-protection products - A review. Int Arch Occup Environ Health 2003;76:355-358.
6. Elsner E, Wigger-Alberti W: Skin-conditioning products in occupational dermatology. Int Arch Occup Environ Health 2003;76:351-354.
7. Berndt U, Wigger-Alberti W, Gabard B, Elsner P: Efficacy of a barrier cream and its vehicle as a protective measure against irritant contact dermatitis. Contact Dermatitis 2000;42:77-80.
8. Wigger-Alberti W, Walter MD, Maraffio B, Wernli M, Elsner P: Self-application of a protective cream: pitfalls of occupational skin protection. Arch Dermatol 1997;133:861-864.
9. De Paepe K, Drede MP, Roseeuw D, Rogiers V: Incorporation of ceramide 3B in dermatocosmetic emulsions: effect on the transepidermal water loss of sodium lauryl sulphate-damaged skin. J Eur Acad Dermatol Venereol 2000;14:272-279.
10. Fluhr JW, Rigano L: Clinical effects of cosmetic vehicles on skin. J Cosmet Sci 2004;55:189-205.
11. Blichmann CW, Serup J, Winther A: Effects of single application of a moisturizer: evaporation of emulsion water, skin surface temperature, electrical conductance, electrical capacitance, and skin surface (emulsion) lipids. Acta Derm Venereol 1989;69:327-330.
12. Fluhr JW, Goor M, Lehmann L, Lazzerini S, Distante F, Berardesca E: Glycerol accelerates recovery of barrier function in vivo. Acta Derm Venereol 1999;79:418-421.
13. Wigger-Alberti W, Elsner P: Do barrier creams and gloves prevent or provoke contact dermatitis? Am J Contact Dermatitis 1998;9:100-106.
14. Hogan DJ, Dannaker CJ, Lal S, Maibach HI: An international survey on the prognosis of occupational contact dermatitis of the hands. Dermatosen 1990;38:143-147.
15. Rosenberg A, Donald A: Evidence-based medicine, an approach to clinical problem-solving. Br Med J 1995;310:1122-1126.
16. Kütting B, Drexler H: Effectiveness of skin protection creams as a preventive measure in occupational dermatitis: a critical update according to criteria of evidence-based medicine. Int Arch Occup Environ Health 2003;76:253-259.
17. Zhai H, Maibach HI: Testing and efficacy of barrier creams; in Fluhr JW, Elsner P, Berardesca E, Maibach HI (eds): Bioengineering of the Skin. Boca Raton, CRC Press, 2005.
18. Boman A, Wahlberg JE, Johansson G: A method for the study of the effect of barrier creams and protective gloves on the percutaneous absorption of solvents. Dermatologica 1982;164:157-160.
19. Mahmoud G, Lachapelle JM, van Neste D: Histological assessment of skin damage by irritants: its possible use in evaluation of a 'barrier cream'. Contact Dermatitis 1984;11:179-185.
20. Goffin V, Piérard-Franchimont C, Piérard GE: Shielded corneosurfametry and corneoxenometry: novel bioassays for the assessment of skin barrier products. Dermatology 1998;196:434.
21. Frosch PJ, Schulze-Dirks A, Hoffmann M, Axthelm I, Kurte A: Efficacy of skin barrier creams. I. The repetitive irritation test (RIT) in the guinea pig. Contact Dermatitis 1993;28:94-100.
22. Schnetz E, Diepgen TL, Elsner P, Frosch PJ, Klotz AJ, Kresken J, Kuss O, Merk H, Schwanitz HJ, Wigger-Alberti W, Fartasch M: Multicentre study for the development of an in vivo model to evaluate the influence of topical formulations on irritation. Contact Dermatitis 2000;42:336-433.
23. Jemec GB, Na R, Wulf HC: The inherent capacitance of moisturizing creams: a source of false-positive results? Skin Pharmacol Appl Skin Physiol 2000;13:182-187.
24. Zhai H, Maibach HI: Effect of barrier creams: human skin in vivo. Contact Dermatitis 1996;35:92.
25. De Fine Olivarius F, et al: Water protective effects of barrier creams and moisturizing creams: a new in vivo test method. Contact Dermatitis 1996;35:219-225.
26. Elsner P, Wigger-Alberti W, Pantini G: Perfluoropolyethers in the prevention of irritant contact dermatitis. Dermatology 1998;197:141.
27. Schliemann-Willers S, Wigger-Alberti W, Elsner P: Efficacy of a new class of perfluoropolyethers in the prevention of irritant contact dermatitis. Acta Derm Venereol 2001;81:392-394.
28. Sun Q, Tran M, Smith B, Winefordner JD: In-situ evaluation of barrier cream performance on human skin using laser-induced breakdown spectroscopy. Contact Dermatitis 2000;43:259.
29. Löffler H, Effendy I: Prevention of irritant contact dermatitis. Eur J Dermatol 2002;12:4-9.
30. Kelterer D, Fluhr JW, Elsner P: Application of protective creams: use of a fluorescence-based training system decreases unprotected areas on the hands. Contact Dermatitis 2003;49:159-160.
31. Maurer T: Guidelines and methods on safety testing for dermatics and cosmetics; in Elsner P, Gabard B, Surber C, Treffel P (eds): Dermatopharmacology of Topical Preparations: A Product-Development Orientated Approach. Berlin, Springer, 2000.
32. Flower C: Safety assessment of cosmetic product; in Leyden JJ, Rawlings AV (eds): Skin Moisturization. New York, Dekker, 2002.
33. Duffy PA, Flint PO: In vitro dermal irritancy tests; in Steele C, Atterwill C (eds): In vitro Methods in Toxicology. Cambridge, Cambridge University, 1987.
34. Oliver GJA, Pemberton MA: An in vitro epidermal slice technique for identifying chemicals with potential for severe cutaneous effects. Food Chem Toxicol 1985;23:229-232.
35. Dykes P, Edwards MJ, O'Donovan MR, Merrett V, Morgan HE, Marks R: In vitro reconstruction of human skin: the use of skin equivalents as potential indicators of cutaneous toxicity. Toxicol In Vitro 1991;5:1-8.
36. Dykes PJ, Pearse AD: Basics on clinical safety testing; in Elsner P, Gabard B, Surber C, Treffel P (eds): Dermatopharmacology of Topical Preparations: A Product-Development Orientated Approach. Berlin, Springer, 2000, pp 79-94.
37. Kaidbey KH, Kligman AM: Identification of topical photosensitizing agents in humans. J Invest Dermatol 1978;70:149-151.
38. Draize JH, Woodward G, Galvery HO: Methods for the study of the irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 1994;83:377-390.
39. Spilker B: Extrapolation of preclinical safety data to humans. Drug News 1991;4:211-216.